Works matching DE "HEMATOLOGICAL oncology"


Results: 446
    1
    2
    3
    4
    5

    Phase II study of carboplatin and gemcitabine as adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: a report from the Central Japan Lung Study Group, CJLSG 0503 trial.

    Published in:
    International Journal of Clinical Oncology, 2010, v. 15, n. 6, p. 583, doi. 10.1007/s10147-010-0118-x
    By:
    • Usami, Noriyasu;
    • Yokoi, Kohei;
    • Hasegawa, Yoshinori;
    • Taniguchi, Hiroyuki;
    • Shindo, Joe;
    • Yamamoto, Masashi;
    • Suzuki, Ryujiro;
    • Imaizumi, Kazuyoshi;
    • Kondo, Masashi;
    • Shimokata, Kaoru
    Publication type:
    Article
    6
    7
    8

    Invasive aspergillosis in a paediatric haematology department: a 15-year review.

    Published in:
    Mycoses, 2008, v. 51, n. 2, p. 109, doi. 10.1111/j.1439-0507.2007.01449.x
    By:
    • Crassard, Nicolas;
    • Hadden, Hélène;
    • Piens, Marie-Antoinette;
    • Pondarr, Corinne;
    • Hadden, Richard;
    • Galambrun, Claire;
    • Pracros, Jean-Pierre;
    • Souillet, Gérard;
    • Basset, Thierry;
    • Berthier, Jean-Claude;
    • Philippe, Noel;
    • Bertrand, Yves
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    20
    21

    Child with oncological diseases in intensive care unit.

    Published in:
    Romanian Journal of Pediatrics / Revista Romana de Pediatrie, 2012, v. 61, n. 4, p. 366
    By:
    • Nistor, N.;
    • Russu, Georgiana;
    • Miron, Ingrith;
    • Ciomaga, Irina-Mihaela;
    • Jitareanu, Cristina;
    • Streanga, Violeta
    Publication type:
    Article
    22

    COPILUL CU AFECŢIUNI ONCOLOGICE ÎN TERAPIA INTENSIVĂ.

    Published in:
    Romanian Journal of Pediatrics / Revista Romana de Pediatrie, 2012, v. 61, n. 4, p. 363
    By:
    • Nistor, N.;
    • Russu, Georgiana;
    • Miron, Ingrith;
    • Ciomaga, Irina-Mihaela;
    • Jităreanu, Cristina;
    • Ştreangă, Violeta
    Publication type:
    Article
    23
    24
    25

    ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets.

    Published in:
    Nature Medicine, 2013, v. 19, n. 2, p. 202, doi. 10.1038/nm.3048
    By:
    • Souers, Andrew J;
    • Leverson, Joel D;
    • Boghaert, Erwin R;
    • Ackler, Scott L;
    • Catron, Nathaniel D;
    • Chen, Jun;
    • Dayton, Brian D;
    • Ding, Hong;
    • Enschede, Sari H;
    • Fairbrother, Wayne J;
    • Huang, David C S;
    • Hymowitz, Sarah G;
    • Jin, Sha;
    • Khaw, Seong Lin;
    • Kovar, Peter J;
    • Lam, Lloyd T;
    • Lee, Jackie;
    • Maecker, Heather L;
    • Marsh, Kennan C;
    • Mason, Kylie D
    Publication type:
    Article
    26

    Cancer: Partners in crime.

    Published in:
    Nature Medicine, 2012, v. 18, n. 9, p. 1348, doi. 10.1038/nm.2946
    By:
    • Farrell, Alison
    Publication type:
    Article
    27
    28

    Hemoglobin Profiles and Hematologic Features of Thalassemic Newborns.

    Published in:
    Archives of Pathology & Laboratory Medicine, 2008, v. 132, n. 11, p. 1739, doi. 10.5858/132.11.1739
    By:
    • Tritipsombut, Jaruwan;
    • Sanchaisuriya, Kanokwan;
    • Fucharoen, Supan;
    • Fucharoen, Goonnapa;
    • Siriratmanawong, Nirut;
    • Pinmuang-ngam, Chamchai;
    • Sanchaisuriya, Pattara
    Publication type:
    Article
    29

    Diagnostic Molecular Pathology.

    Published in:
    Archives of Pathology & Laboratory Medicine, 2006, v. 130, n. 9, p. 1339, doi. 10.5858/2006-130-1339-dmpaii
    By:
    • Netto, George J.;
    • Saad, Rana Domiati
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40

    (Re)Minding the obvious.

    Published in:
    Hematological Oncology, 2024, v. 42, n. 6, p. 1, doi. 10.1002/hon.3182
    By:
    • Weinstock, David
    Publication type:
    Article
    41
    43
    44

    Erratum.

    Published in:
    2021
    Publication type:
    Correction Notice
    45

    Erratum.

    Published in:
    2021
    Publication type:
    Correction Notice
    46
    47
    48

    MAINTENANCE RITUXIMAB IS ASSOCIATED WITH IMPROVED OVERALL SURVIVAL IN MANTLE CELL LYMPHOMA PATIENTS RESPONDING TO INDUCTION THERAPY WITH BENDAMUSTINE + RITUXIMAB (BR).

    Published in:
    Hematological Oncology, 2019, v. 37, p. 405, doi. 10.1002/hon.75_2631
    By:
    • Hill, B.T.;
    • Switchenko, J.M.;
    • Martin, P.;
    • Churnetski, M.C.;
    • Sawalha, Y.;
    • Goyal, S.;
    • Shanmugasundaram, K.;
    • Calzada, O.;
    • Kolla, B.;
    • Bachanova, V.;
    • Gerson, J.N.;
    • Barta, S.K.;
    • Maldonado, E.;
    • Gordon, M.;
    • Danilov, A.;
    • Grover, N.S.;
    • Mathews, S.;
    • Burkart, M.;
    • Karmali, R.;
    • Ghosh, N.
    Publication type:
    Article
    49

    LONG‐TERM EFFICACY AND SAFETY OF LENALIDOMIDE MAINTENANCE IN PATIENTS WITH RELAPSED DIFFUSE LARGE B‐CELL LYMPHOMA WHO ARE NOT ELIGIBLE FOR AUTOLOGOUS TRANSPLANTATION (ASCT).

    Published in:
    Hematological Oncology, 2019, v. 37, p. 256, doi. 10.1002/hon.65_2630
    By:
    • Ferreri, A.J.;
    • Sassone, M.C.;
    • Angelillo, P.;
    • Zaja, F.;
    • Re, A.;
    • Spina, M.;
    • Di Rocco, A.;
    • Fabbri, A.;
    • Stelitano, C.;
    • Frezzato, M.;
    • Rusconi, C.;
    • Zambello, R.;
    • Arcari, A.;
    • Bertoldero, G.;
    • De Lorenzo, D.;
    • Volpetti, S.;
    • Calimeri, T.;
    • Perrone, S.;
    • Cecchetti, C.;
    • Ciceri, F.
    Publication type:
    Article
    50